Extreme Medicine

ORIGINAL RESEARCH

Modern approaches to assessment of minimal residual disease in multiple myeloma (plasma cell myeloma) cases

Glazanova TV, Shilova ER, Bessmeltsev SS

Russian Research Institute of Hematology and Transfusiology of the Federal Medical-Biological Agency, Saint Petersburg, Russia

Correspondence should be addressed: Tatyana V. Glazanova
2nd Sovetskaya str., 16, St. Petersburg, 191023, Russia; ur.xednay@avonazalg-anaytat

About paper

Author contributions: TV Glazanova — concept development, collection and analysis of literature; ER Shilova — article editing, authoring; SS Bessmeltsev — article editing, approval of its final version.

Received: 2023-11-16 Accepted: 2023-12-20 Published online: 2023-12-31

Table. Comparison of MRD assessment methods utilizing BM samples [7]

Link to the next paper will be sent to the indicated e-mail's:

ORIGINAL RESEARCH Modern approaches to assessment of minimal residual disease in multiple myeloma (plasma cell myeloma) cases

Glazanova TV, Shilova ER, Bessmeltsev SS

Published in "Bulletin of RSMU" 4, 2023

I want to receive a copy of this message

Vancouver style

Glazanova TV, Shilova ER, Bessmeltsev SS. Modern approaches to assessment of minimal residual disease in multiple myeloma (plasma cell myeloma) cases. Extreme Medicine. 2023; (4): 10–8. DOI: 10.47183/mes.2023.062

Harvard style

Glazanova, T. V., Shilova, E. R. and Bessmeltsev, S. S. (2023), "Modern approaches to assessment of minimal residual disease in multiple myeloma (plasma cell myeloma) cases", Extreme Medicine, no. 4, p. 10–18. DOI: 10.47183/mes.2023.062

Remember me

Forgot password?

I accept Editorial Policies of the journal

Archive

2023 / 04

ORIGINAL RESEARCH

Modern approaches to assessment of minimal residual disease in multiple myeloma (plasma cell myeloma) cases